Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q3 2024 Earnings Call Transcript
Operator: Good afternoon. And welcome to Cumberland Pharmaceuticals Third Quarter 2024 Financial Report and Company Update.
Cumberland Pharmaceuticals Inc (CPIX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 528,163 | $676,049 | -2% | 0% |
| 2. | 44,200 | $56,576 | +83% | 0% | |
| 3. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 10,000 | $12,800 | 0% | |
| 4. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.20 | 31 | Director | 29,017 | 2024-10-31 | Filing | |
| $1.32 | 31 | Director | 28,986 | 2024-10-30 | Filing | |
| $1.24 | 31 | Director | 28,955 | 2024-10-29 | Filing | |
| $1.25 | 31 | Director | 28,924 | 2024-10-28 | Filing | |
| $1.23 | 31 | Director | 28,893 | 2024-10-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.79 | 1,000 | Director | 0 | 2019-12-04 | Filing | |
| $5.31 | 3,470 | Director | 1,000 | 2019-09-25 | Filing | |
| $5.27 | 4,400 | Director | 4,470 | 2019-09-23 | Filing | |
| $5.31 | 3,700 | Director | 8,870 | 2019-09-20 | Filing | |
| $5.21 | 4,000 | Director | 12,170 | 2019-09-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 374,251 | $670,546 | 0% | |
| 2. | 365,934 | $636,725 | 0% | |
| 3. | 286,655 | $498,780 | 0.01% | |
| 4. | 110,990 | $198,860 | 0% | |
| 5. | 85,274 | $148,397 | 0% |
News See All
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q2 2024 Earnings Call Transcript
Operator: Good afternoon. And welcome to Cumberland Pharmaceuticals Second Quarter 2024 Financial Report and Company Update.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to Cumberland Pharmaceuticals First Quarter 2024 Financial Report and Company Update.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Cumberland Pharmaceuticals 2023 Financial Report and Company Update.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Cumberland Pharmaceuticals Third Quarter 2023 Company Update and Financial Report.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Cumberland Pharmaceuticals' Second Quarter 2023 Company Update and Financial Report.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Cumberland Pharmaceuticals First Quarter 2023 Company Update and Financial Report.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to Cumberland Pharmaceuticals' 2022 Financial Report and Company Update.
Cumberland Pharmaceuticals, Inc. (CPIX): Are Hedge Funds Right About This Stock?
A whopping number of 13F filings filed with U.S.
Where Do Hedge Funds Stand On Cumberland Pharmaceuticals, Inc. (CPIX)?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September...